300238.SZ · 冠昊生物
China A-shares · RS rating 33 · As of 2026-10-14
| Price | 11.15 CNY |
|---|---|
| 1-day change | -2.1% |
| RS rating (overall / 1M / 3M / 12M) | 33 / 60 / 48 / 28 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 15 / 8 / 6 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -13.2% |
| Distance from 52-week high | +37.5% |
| Market cap (USD) | $485.6M |